HETEROARILAMINOSULFONAMIDAS DE 5 MIEMBROS PARA TRATAR AFECCIONES MEDIADAS POR UNA ACTIVIDAD DEFICIENTE DE CFTR
La invenci?n est? relacionada con compuestos de heteroarilo, sales farmac?uticamente aceptables de estos, y preparaciones farmac?uticas de estos. En la presente tambi?n se describen composiciones y el uso de esos compuestos en m?todos de tratamiento de enfermedades y afecciones mediadas por la defic...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BALTZER, Sylvie NESTLER, Hans WIRE, William MA, Nina HARTUNG, Ryan GAO, Zhongli YEOMAN, Helen LIAO, Junkai HURLBUT, Gregory MECHIN, Ingrid THURAIRATNAM, Sukanthini VIVET, Bertrand FREED, Brian MUNSON, Mark SMRCINA, Martin LEBRETON, Sylvain |
| description | La invenci?n est? relacionada con compuestos de heteroarilo, sales farmac?uticamente aceptables de estos, y preparaciones farmac?uticas de estos. En la presente tambi?n se describen composiciones y el uso de esos compuestos en m?todos de tratamiento de enfermedades y afecciones mediadas por la deficiencia de la actividad del CFTR, en particular la fibrosis qu?stica.
The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ECSP22046050A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ECSP22046050A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ECSP22046050A3</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeodBvdCqdb9mEzoQJOUSeq2FIkrqYV6f0zBA7j6b_He3xZTQ5HEo3CLlp0PfWu8y6gxgCaowTLZm_gAHQpCFIwogIaUYu8ogCXNuNqdF-gdAqrI99zr3BtWTC7SeqVMlH2xeY6vJR1-uyuOhqJqTml-D2mZx0ea0mcgFbqqKi_Xsi7x_Jf0Bb1GN5Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROARILAMINOSULFONAMIDAS DE 5 MIEMBROS PARA TRATAR AFECCIONES MEDIADAS POR UNA ACTIVIDAD DEFICIENTE DE CFTR</title><source>esp@cenet</source><creator>BALTZER, Sylvie ; NESTLER, Hans ; WIRE, William ; MA, Nina ; HARTUNG, Ryan ; GAO, Zhongli ; YEOMAN, Helen ; LIAO, Junkai ; HURLBUT, Gregory ; MECHIN, Ingrid ; THURAIRATNAM, Sukanthini ; VIVET, Bertrand ; FREED, Brian ; MUNSON, Mark ; SMRCINA, Martin ; LEBRETON, Sylvain</creator><creatorcontrib>BALTZER, Sylvie ; NESTLER, Hans ; WIRE, William ; MA, Nina ; HARTUNG, Ryan ; GAO, Zhongli ; YEOMAN, Helen ; LIAO, Junkai ; HURLBUT, Gregory ; MECHIN, Ingrid ; THURAIRATNAM, Sukanthini ; VIVET, Bertrand ; FREED, Brian ; MUNSON, Mark ; SMRCINA, Martin ; LEBRETON, Sylvain</creatorcontrib><description>La invenci?n est? relacionada con compuestos de heteroarilo, sales farmac?uticamente aceptables de estos, y preparaciones farmac?uticas de estos. En la presente tambi?n se describen composiciones y el uso de esos compuestos en m?todos de tratamiento de enfermedades y afecciones mediadas por la deficiencia de la actividad del CFTR, en particular la fibrosis qu?stica.
The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220831&DB=EPODOC&CC=EC&NR=SP22046050A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220831&DB=EPODOC&CC=EC&NR=SP22046050A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BALTZER, Sylvie</creatorcontrib><creatorcontrib>NESTLER, Hans</creatorcontrib><creatorcontrib>WIRE, William</creatorcontrib><creatorcontrib>MA, Nina</creatorcontrib><creatorcontrib>HARTUNG, Ryan</creatorcontrib><creatorcontrib>GAO, Zhongli</creatorcontrib><creatorcontrib>YEOMAN, Helen</creatorcontrib><creatorcontrib>LIAO, Junkai</creatorcontrib><creatorcontrib>HURLBUT, Gregory</creatorcontrib><creatorcontrib>MECHIN, Ingrid</creatorcontrib><creatorcontrib>THURAIRATNAM, Sukanthini</creatorcontrib><creatorcontrib>VIVET, Bertrand</creatorcontrib><creatorcontrib>FREED, Brian</creatorcontrib><creatorcontrib>MUNSON, Mark</creatorcontrib><creatorcontrib>SMRCINA, Martin</creatorcontrib><creatorcontrib>LEBRETON, Sylvain</creatorcontrib><title>HETEROARILAMINOSULFONAMIDAS DE 5 MIEMBROS PARA TRATAR AFECCIONES MEDIADAS POR UNA ACTIVIDAD DEFICIENTE DE CFTR</title><description>La invenci?n est? relacionada con compuestos de heteroarilo, sales farmac?uticamente aceptables de estos, y preparaciones farmac?uticas de estos. En la presente tambi?n se describen composiciones y el uso de esos compuestos en m?todos de tratamiento de enfermedades y afecciones mediadas por la deficiencia de la actividad del CFTR, en particular la fibrosis qu?stica.
The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeodBvdCqdb9mEzoQJOUSeq2FIkrqYV6f0zBA7j6b_He3xZTQ5HEo3CLlp0PfWu8y6gxgCaowTLZm_gAHQpCFIwogIaUYu8ogCXNuNqdF-gdAqrI99zr3BtWTC7SeqVMlH2xeY6vJR1-uyuOhqJqTml-D2mZx0ea0mcgFbqqKi_Xsi7x_Jf0Bb1GN5Y</recordid><startdate>20220831</startdate><enddate>20220831</enddate><creator>BALTZER, Sylvie</creator><creator>NESTLER, Hans</creator><creator>WIRE, William</creator><creator>MA, Nina</creator><creator>HARTUNG, Ryan</creator><creator>GAO, Zhongli</creator><creator>YEOMAN, Helen</creator><creator>LIAO, Junkai</creator><creator>HURLBUT, Gregory</creator><creator>MECHIN, Ingrid</creator><creator>THURAIRATNAM, Sukanthini</creator><creator>VIVET, Bertrand</creator><creator>FREED, Brian</creator><creator>MUNSON, Mark</creator><creator>SMRCINA, Martin</creator><creator>LEBRETON, Sylvain</creator><scope>EVB</scope></search><sort><creationdate>20220831</creationdate><title>HETEROARILAMINOSULFONAMIDAS DE 5 MIEMBROS PARA TRATAR AFECCIONES MEDIADAS POR UNA ACTIVIDAD DEFICIENTE DE CFTR</title><author>BALTZER, Sylvie ; NESTLER, Hans ; WIRE, William ; MA, Nina ; HARTUNG, Ryan ; GAO, Zhongli ; YEOMAN, Helen ; LIAO, Junkai ; HURLBUT, Gregory ; MECHIN, Ingrid ; THURAIRATNAM, Sukanthini ; VIVET, Bertrand ; FREED, Brian ; MUNSON, Mark ; SMRCINA, Martin ; LEBRETON, Sylvain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ECSP22046050A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BALTZER, Sylvie</creatorcontrib><creatorcontrib>NESTLER, Hans</creatorcontrib><creatorcontrib>WIRE, William</creatorcontrib><creatorcontrib>MA, Nina</creatorcontrib><creatorcontrib>HARTUNG, Ryan</creatorcontrib><creatorcontrib>GAO, Zhongli</creatorcontrib><creatorcontrib>YEOMAN, Helen</creatorcontrib><creatorcontrib>LIAO, Junkai</creatorcontrib><creatorcontrib>HURLBUT, Gregory</creatorcontrib><creatorcontrib>MECHIN, Ingrid</creatorcontrib><creatorcontrib>THURAIRATNAM, Sukanthini</creatorcontrib><creatorcontrib>VIVET, Bertrand</creatorcontrib><creatorcontrib>FREED, Brian</creatorcontrib><creatorcontrib>MUNSON, Mark</creatorcontrib><creatorcontrib>SMRCINA, Martin</creatorcontrib><creatorcontrib>LEBRETON, Sylvain</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BALTZER, Sylvie</au><au>NESTLER, Hans</au><au>WIRE, William</au><au>MA, Nina</au><au>HARTUNG, Ryan</au><au>GAO, Zhongli</au><au>YEOMAN, Helen</au><au>LIAO, Junkai</au><au>HURLBUT, Gregory</au><au>MECHIN, Ingrid</au><au>THURAIRATNAM, Sukanthini</au><au>VIVET, Bertrand</au><au>FREED, Brian</au><au>MUNSON, Mark</au><au>SMRCINA, Martin</au><au>LEBRETON, Sylvain</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROARILAMINOSULFONAMIDAS DE 5 MIEMBROS PARA TRATAR AFECCIONES MEDIADAS POR UNA ACTIVIDAD DEFICIENTE DE CFTR</title><date>2022-08-31</date><risdate>2022</risdate><abstract>La invenci?n est? relacionada con compuestos de heteroarilo, sales farmac?uticamente aceptables de estos, y preparaciones farmac?uticas de estos. En la presente tambi?n se describen composiciones y el uso de esos compuestos en m?todos de tratamiento de enfermedades y afecciones mediadas por la deficiencia de la actividad del CFTR, en particular la fibrosis qu?stica.
The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ECSP22046050A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | HETEROARILAMINOSULFONAMIDAS DE 5 MIEMBROS PARA TRATAR AFECCIONES MEDIADAS POR UNA ACTIVIDAD DEFICIENTE DE CFTR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A10%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BALTZER,%20Sylvie&rft.date=2022-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EECSP22046050A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |